Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01075607 · ClinicalTrials.gov registry record
Lymph Fluid and Blood Collection for Identification of Novel Biomarkers
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 50
- Enrollment target
NCT01075607 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 50 participants.
The verdict
NCT01075607 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The objective of this study is to identify and validate metastasis protein markers in lymph collected from women with metastatic breast cancer. We will examine peripheral blood for the presence of these identified markers in order to develop a user friendly clinical test to detect metastasis and to evaluate response to therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-04 |
| Est. Completion | 2022-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01075607
The ClinicalTrials.gov registry entry for NCT01075607 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01075607 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01075607 about?
NCT01075607 is a clinical study titled "Lymph Fluid and Blood Collection for Identification of Novel Biomarkers". The objective of this study is to identify and validate metastasis protein markers in lymph collected from women with metastatic breast cancer. We will examine peripheral blood for the presence of these identified markers in order to develop a user friendly clinical test to detect metastasis and to ...
What is the current status of trial NCT01075607?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2010-04. Estimated completion is 2022-04.
Who is sponsoring clinical trial NCT01075607?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.